The Orthofix SpinalStim you’re seeing here was given to me by a friend after their doctor said the therapy could be cut short. This provided a somewhat rare opportunity to observe the device ...

Julie Andrews, Orthofix's CFO, sold 4,655 shares of common stock on Jan. 16, according to a Jan. 21 SEC filing.

Canaccord Genuity initiates coverage on Orthofix Medical with a Buy rating and $24 price target, citing growth potential and strong financial outlook.

Julie Andrews, the Chief Financial Officer of Orthofix Medical (TASE:PMCN) Inc. (NASDAQ:OFIX), recently sold a portion of her holdings in the company. According to a recent filing, Andrews sold 4,655 ...

Fintel reports that on January 22, 2025, Canaccord Genuity initiated coverage of Orthofix Medical (NasdaqGS:OFIX) with a Buy ...

Orthofix Medical, Inc. engages in the provision of medical devices. It operates through the following business segments: Global Spine and Global Extremities. The Global Spine reporting segment ...

GET MORE AI-GENERATED SIGNALS: January 16, 2025, 22:48 pm ET, BY Bill T.- Contributor| Editor: Thomas H. Kee Jr. ( Follow on ...

DelveInsight Analysis: The Orthopedic Trauma Devices market size is expected to grow at a CAGR of 6.43% during the forecast period (201-26) to reach USD 10.08 billion by 2030. Which MedTech key ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.